Barinthus Biotherapeutics plc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE15-12GBarinthus Biotherapeutics plc.BRNSSep 21

   Deregistration notice

2. ROUTINEEFFECTBarinthus Biotherapeutics plc.BRNSSep 15

   Registration declared effective

3. ROUTINESCHEDULE 13G/ABarinthus Biotherapeutics plc.BRNSSep 11

   Ownership stake disclosure by Oxford Science Enterprises plc (amended)

   Oxford Science Enterprises plc, filed by

4. ROUTINE4/ABarinthus Biotherapeutics plc.BRNSSep 11

   Oxford Science Enterprises plc, insider filing for BRNS (amended)

   Oxford Science Enterprises plc, reporting

5. ROUTINE25Barinthus Biotherapeutics plc.BRNSSep 9

   Form 25 filing

6. ROUTINE4Barinthus Biotherapeutics plc.BRNSSep 9

   8 insider filings

   Robin Wright, insider filing for BRNS

   Show all 8

   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9
   • 4Insider filing for BRNSSep 9

   Robin Wright, reporting

7. ROUTINEPOS AMBarinthus Biotherapeutics plc.BRNSSep 9

   POS AM filing

8. ROUTINES-8 POSBarinthus Biotherapeutics plc.BRNSSep 9

   S-8 POS filing

9. ROUTINES-8 POSBarinthus Biotherapeutics plc.BRNSSep 9

   S-8 POS filing

10. ROUTINES-8 POSBarinthus Biotherapeutics plc.BRNSSep 9

    S-8 POS filing

11. ROUTINES-8 POSBarinthus Biotherapeutics plc.BRNSSep 9

    S-8 POS filing

12. ROUTINES-8 POSBarinthus Biotherapeutics plc.BRNSSep 9

    S-8 POS filing

13. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSSep 9

    Current report

14. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSSep 1

    Current report

15. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSAug 25

    Current report

16. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSAug 6

    Current report

17. NOTABLE10-QBarinthus Biotherapeutics plc.BRNSAug 6

    Quarterly report

18. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSJul 2

    Current report

19. ROUTINEARSBarinthus Biotherapeutics plc.BRNSJun 10

    Annual report to shareholders

20. ROUTINEDEF 14ABarinthus Biotherapeutics plc.BRNSJun 10

    Proxy statement

21. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSMay 21

    Current report

22. ROUTINE3Barinthus Biotherapeutics plc.BRNSMay 1

    Douglas J Swirsky, new insider at BRNS

    Douglas J Swirsky, reporting

23. NOTABLE10-QBarinthus Biotherapeutics plc.BRNSApr 30

    Quarterly report

24. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSApr 30

    Current report

25. NOTABLEDEFM14ABarinthus Biotherapeutics plc.BRNSApr 30

    Merger proxy statement

26. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSApr 22

    Current report

27. NOTABLESCHEDULE 13DBarinthus Biotherapeutics plc.BRNSApr 13

    Ownership stake disclosure by International Generosity Foundation Trust

    International Generosity Foundation Trust, filed by

28. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSMar 31

    Current report

29. NOTABLE10-KBarinthus Biotherapeutics plc.BRNSMar 13

    Annual report

30. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSMar 13

    Current report

31. ROUTINE425Barinthus Biotherapeutics plc.BRNSFeb 23

    Merger communication

32. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSFeb 23

    Current report

33. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSJan 6

    Current report

34. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSDec 10, 2025

    Current report

35. NOTABLE10-QBarinthus Biotherapeutics plc.BRNSNov 7, 2025

    Quarterly report

36. ROUTINE8-KBarinthus Biotherapeutics plc.BRNSNov 7, 2025

    Current report

Older filings on EDGAR